Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4LLD

Structure of wild-type IgG1 antibody heavy chain constant domain 1 and light chain lambda constant domain (IgG1 CH1:Clambda) at 1.19A

4LLD の概要
エントリーDOI10.2210/pdb4lld/pdb
関連するPDBエントリー4LLM 4LLQ 4LLU 4LLW 4LLY
分子名称Ig gamma-1 chain C region, Ig lambda-2 chain C region (3 entities in total)
機能のキーワードigg domain, fragment of antibody, immune system
由来する生物種Homo sapiens (human)
詳細
細胞内の位置Secreted: P01857
タンパク質・核酸の鎖数2
化学式量合計25315.12
構造登録者
主引用文献Lewis, S.M.,Wu, X.,Pustilnik, A.,Sereno, A.,Huang, F.,Rick, H.L.,Guntas, G.,Leaver-Fay, A.,Smith, E.M.,Ho, C.,Hansen-Estruch, C.,Chamberlain, A.K.,Truhlar, S.M.,Conner, E.M.,Atwell, S.,Kuhlman, B.,Demarest, S.J.
Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface.
Nat.Biotechnol., 32:191-198, 2014
Cited by
PubMed Abstract: Robust generation of IgG bispecific antibodies has been a long-standing challenge. Existing methods require extensive engineering of each individual antibody, discovery of common light chains, or complex and laborious biochemical processing. Here we combine computational and rational design approaches with experimental structural validation to generate antibody heavy and light chains with orthogonal Fab interfaces. Parental monoclonal antibodies incorporating these interfaces, when simultaneously co-expressed, assemble into bispecific IgG with improved heavy chain-light chain pairing. Bispecific IgGs generated with this approach exhibit pharmacokinetic and other desirable properties of native IgG, but bind target antigens monovalently. As such, these bispecific reagents may be useful in many biotechnological applications.
PubMed: 24463572
DOI: 10.1038/nbt.2797
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.19 Å)
構造検証レポート
Validation report summary of 4lld
検証レポート(詳細版)ダウンロードをダウンロード

250059

件を2026-03-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon